Sutro Biopharma Inc (FRA:S090)
€ 20.6 -1 (-4.63%) Market Cap: 305.96 Mil Enterprise Value: 172.93 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 46/100

Sutro Biopharma Inc at TD Cowen Healthcare Conference Transcript

Mar 04, 2026 / 06:50PM GMT
Release Date Price: €16.4 (-2.38%)
Tara Bancroft
Cowen and Company LLC - Analyst

All right, we're going to get started. Hi, everyone. My name is Tara Bancroft. I'm one of the senior biotech analysts here at TD Cowen. Thank you so much for joining us at TD Cowen's 46th Annual Healthcare Conference.

So the next session here, we have a presentation followed by some Q&A with Sutro. And from Sutro, we have the CEO, Jane Chung. Jane, it's so wonderful to have you here. It's such a privilege.

So you can get started on your presentation whenever you're ready, and I'll join you back up here for Q&A after.

Jane Chung
Sutro Biopharma Inc - President, Chief Executive Officer, Director

Great. So thank you, Tara. Thank you for the opportunity. It's a pleasure to be here at the TD Cowen Conference and share the new Sutro story with all of you.

I've been the CEO now since March of last year, and this past year we've done a lot of work to transform the Sutro business. And actually we've right-sized the team, we've extended our runway several times and we've accelerated our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot